Company Profiles

driven by the PitchBook Platform

Esperance Pharmaceuticals

Description

Provider of therapeutic services for cancer. The company engages in the development of anticancer drugs that selectively kill cancer cells without harming normal cells.

2005

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$40M

Latest Deal Amount

$64M

Total Amount Raised

Description

Provider of therapeutic services for cancer. The company engages in the development of anticancer drugs that selectively kill cancer cells without harming normal cells.

Website:

www.esperancepharma.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery

Primary Office

909 Fannin Street Suite 2000 Houston, TX 77010United States +1 (610) 291-0307
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Esperance Pharmaceuticals's full profile, request a free trial.

    Esperance Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Esperance Pharmaceuticals Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Esperance Pharmaceuticals Investors (6)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Advantage Capital (St. Louis)Venture CapitalMinority000 0000000 0000
    BVM CapitalVenture CapitalMinority000 0000000 0000
    Louisiana FundVenture CapitalMinority000 0000000 0000
    Research Corporation TechnologiesVenture CapitalMinority000 0000000 0000
    Sanofi-Genzyme BioventuresCorporate Venture CapitalMinority000 0000000 0000
    Advantage Capital (St. Louis) Venture Capital
    BVM Capital Venture Capital
    Louisiana Fund Venture Capital
    Research Corporation Technologies Venture Capital
    Sanofi-Genzyme Bioventures Corporate Venture Capital

    Esperance Pharmaceuticals Executive Team (5)

    NameTitleBoard
    Seat
    Contact
    Info
    Melany AdamcioDirector, Clinical Operations
    Hector Alila Ph.DFounder, Chief Executive Officer, President and Board Member
    Carola LeuschnerVice President, Research & Development
    Clarice MotterInterim Chief Financial Officer & Controller
    Joseph LovettChairman
    Melany Adamcio Director, Clinical Operations
    Hector Alila Ph.D Founder, Chief Executive Officer, President and Board Member
    Carola Leuschner Vice President, Research & Development
    Clarice Motter Interim Chief Financial Officer & Controller
    Joseph Lovett Chairman

    Esperance Pharmaceuticals Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Brett Giroir MDSelfBoard Member000 0000
    Hector Alila Ph.DEsperance PharmaceuticalsFounder, Chief Executive Officer, President and Board Member000 0000
    Joseph LovettSelfChairman000 0000
    Ross Barrett JDBVM CapitalGeneral Partner & Co-Founder000 0000
    Brett Giroir MD Board Member Self
    Hector Alila Ph.D Founder, Chief Executive Officer, President and Board Member Esperance Pharmaceuticals
    Joseph Lovett Chairman Self
    Ross Barrett JD General Partner & Co-Founder BVM Capital
    Request full access to PitchBook